Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BPL HRIG for Rabies Post-Exposure Prophylaxis
NCT03264157Phase 3Completed
- Sponsor
- Bio Products Laboratory
- Start
- Dec 2017
- Primary completion
- Mar 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of BPL human rabies immune globulin in rabies, sponsored by Bio Products Laboratory. Started Dec 2017; status: completed.
02
Drugs
BPL human rabies immune globulin
03
Conditions
rabies
Beyond the preview
Go deeper on NCT03264157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03264157.